Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Letters

• Publication date

  2017-01-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2016.10.020PMID 27773750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.

  2014cited by this paper
• Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis

  2014cited by this paper
• Metabolic control of YAP and TAZ by the mevalonate pathway

  2014cited by this paper
• Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression

  2014cited by this paper
• Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility

  2013cited by this paper
• Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair

  2013cited by this paper
• Malignant mesothelioma: Facts, Myths, and Hypotheses

  2012cited by this paper
• Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents.

  2012cited by this paper
• YAP is a candidate oncogene for esophageal squamous cell carcinoma.

  2011cited by this paper
• The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

  2011cited by this paper
• CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

  2011cited by this paper
• The Use of Pleural Fluid sCD44v6/std Ratio for Distinguishing Mesothelioma from Other Pleural Malignancies

  2011cited by this paper
• Germline BAP1 mutations predispose to malignant mesothelioma

  2011cited by this paper
• LATS2 is a tumor suppressor gene of malignant mesothelioma.

  2011cited by this paper
• Simvastatin Prevents Skeletal Metastasis of Breast Cancer by an Antagonistic Interplay between p53 and CD44*

  2011cited by this paper
• The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

  2011cited by this paper
• The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

  2011cited by this paper
• Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

  2010cited by this paper
• Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB

  2010cited by this paper
• Dysregulation of the mevalonate pathway promotes transformation

  2010cited by this paper
• Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

  2010cited by this paper
• The hippo signaling pathway in development and cancer.

  2010cited by this paper
• Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells

  2010cited by this paper
• Herding Hippos: regulating growth in flies and man.

  2009cited by this paper
• Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

  2009cited by this paper
• Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis

  2008cited by this paper
• YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation.

  2008cited by this paper
• Hippo signaling in organ size control.

  2007cited by this paper
• Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma

  2007cited by this paper
• The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network

  2007cited by this paper
• Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer Patients

  2007cited by this paper
• Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

  2006cited by this paper
• Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

  2006cited by this paper
• Targeting of CD44 eradicates human acute myeloid leukemic stem cells

  2006cited by this paper
• Prospective identification of tumorigenic prostate cancer stem cells.

  2005cited by this paper
• The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.

  2005cited by this paper
• Advances in malignant mesothelioma.

  2005cited by this paper
• Statins and cancer prevention

  2005cited by this paper
• Extracellular matrix remodelling: the role of matrix metalloproteinases

  2003cited by this paper
• CD44: From adhesion molecules to signalling regulators

  2003cited by this paper
• Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

  2003cited by this paper
• salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.

  2002cited by this paper
• Splice variant expression of CD44 in patients with breast and ovarian cancer.

  2001cited by this paper
• The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

  2001cited by this paper
• Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction

  1999cited by this paper
• Lovastatin induces apoptosis in malignant mesothelioma cells.

  1998cited by this paper
• High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

  1995cited by this paper
• Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.

  1995cited by this paper
• CD44 isoforms in metastatic cancer.

  1994cited by this paper
• Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.

  1994cited by this paper

• CD44 variant exons induce chemoresistance by modulating cell death pathways

  2025cites this paper
• Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1

  2025cites this paper
• Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma.

  2025cites this paper
• Age-specific protective effects of statins against cirrhosis in patients with chronic liver enzyme elevation associated with metabolic dysfunction: a retrospective cohort study of electronic health records

  2025cites this paper
• Atorvastatin exhibits anticancer effects by inhibiting YAP/TAZ activity in mesenchymal-like non-small cell lung cancer

  2025cites this paper
• Statins exhibit anti-tumor potential by modulating Wnt/β-catenin signaling in colorectal cancer

  2025cites this paper
• Statins and adhesion molecules: a review of a novel pleiotropic property of statins

  2025cites this paper
• BaZiBuShen inhibition of oocyte ferroptosis in primordial follicles through activation of NF2-YAP pathway for the treatment of chemotherapy-induced premature ovarian insufficiency.

  2025cites this paper
• Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma.

  2024cites this paper
• CD44 and its implication in neoplastic diseases

  2024cites this paper
• Statins as anti‐tumor agents: A paradigm for repurposed drugs

  2024cites this paper
• Statins attenuate Wnt/β-catenin signaling by targeting SATB family proteins in colorectal cancer

  2024cites this paper
• NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity

  2024cites this paper
• Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies

  2024cites this paper
• Simvastatin Attenuates Glucocorticoid-Induced Human Trabecular Meshwork Cell Dysfunction via YAP/TAZ Inactivation

  2023cites this paper
• Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis

  2023cites this paper
• Development of a New HiBiT Biosensor Monitoring Stability of YAP/TAZ Proteins in Cells

  2023cites this paper
• Unraveling the prevalence of various signalling pathways in non-small-cell lung cancer: a review

  2023cites this paper
• BNC1 deficiency-triggered ferroptosis through the NF2-YAP pathway induces primary ovarian insufficiency

  2022cites this paper
• Atherosclerosis and Endothelial Mechanotransduction: Current Knowledge and Models for Future Research.

  2022cites this paper
• Extracellular Vesicles Isolated from Malignant Mesothelioma Cancer-Associated Fibroblasts Induce Pro-Oncogenic Changes in Healthy Mesothelial Cells

  2022cites this paper
• Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma

  2022cites this paper
• Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer

  2021cites this paper
• Nrf2, YAP, antioxidant potential, and cancer

  2021cites this paper
• Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction

  2021cites this paper
• Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

  2021cites this paper
• Asbestos‐induced mesothelial injury and carcinogenesis: Involvement of iron and reactive oxygen species

  2021cites this paper
• Steps in metastasis: an updated review

  2021cites this paper
• A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression

  2021influential citation
• Frequent NF2 Inactivation in Mesothelioma: How Can We Treat Mesothelioma with Targeted Therapies for Molecular Aberrations?

  2021cites this paper
• Mechanical Cues Affect Migration and Invasion of Cells From Three Different Directions

  2020cites this paper
• Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling

  2020cites this paper
• Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis.

  2020cites this paper
• Hippo Signaling Pathway has a critical role in Zika Virus Replication and in the Pathogenesis of Neuroinflammation

  2020cites this paper
• Targeting ERK-Hippo Interplay in Cancer Therapy

  2020cites this paper
• Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge

  2020cites this paper
• Statins use and its impact in EGFR‐TKIs resistance to prolong the survival of lung cancer patients: A Cancer registry cohort study in Taiwan

  2020cites this paper
• Emerging agents that target signaling pathways in cancer stem cells

  2020cites this paper
• Establishment of a low-tumorigenic MDCK cell line and study of differential molecular networks.

  2020cites this paper
• Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells

  2020cites this paper
• Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

  2020cites this paper
• YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine

  2019cites this paper
• Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity

  2019cites this paper
• Prediction of putative small molecules for manipulation of enriched signalling pathways in hESC-derived early cardiovascular progenitors by bioinformatics analysis.

  2019cites this paper
• R‐spondin 2 Drives Liver Tumor Development in a Yes‐Associated Protein‐Dependent Manner

  2019cites this paper
• CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling

  2019cites this paper
• New Insights into the Roles of Yes-Associated Protein (YAP1) in Colorectal Cancer Development and Progression

  2019cites this paper
• Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages.

  2018cites this paper
• The hippo pathway provides novel insights into lung cancer and mesothelioma treatment

  2018cites this paper
• Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways

  2018cites this paper
• Effects of Simvastatin on the Viability and Secretion of Vascular Endothelial Growth Factor of Cell Spheroids Cultured in Growth Media

  2018cites this paper
• Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma

  2018cites this paper
• YAP effect on C6 glioma stem cell properities

  2018cites this paper
• Peptide 17, an inhibitor of YAP/TEAD4 pathway, mitigates lung cancer malignancy

  2018cites this paper
• Unbalanced YAP–SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma

  2018cites this paper
• Upregulated microRNA miR-21 promotes the progression of lung adenocarcinoma through inhibition of KIBRA and the Hippo signaling pathway.

  2018cites this paper
• Effects of statins on the chemoresistance-The antagonistic drug-drug interactions versus the anti-cancer effects.

  2018cites this paper
• Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.

  2018cites this paper
• Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism.

  2018cites this paper
• NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma

  2018cites this paper
• The Hippo pathway in normal development and cancer

  2018cites this paper
• Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation

  2018cites this paper
• The Hippo signaling pathway: an emerging anti-cancer drug target.

  2017cites this paper
• Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma

  2017influential citation
• CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives

  2017cites this paper